Home›Companies›Biotech & Pharma›Caldera Therapeutics

Caldera Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 21, 2026·Suggest an edit

About Caldera Therapeutics

Caldera Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2025 in Delaware. It has reported $37,500,000 raised in one offering on Form D since January 2026. Its chief executive is Praveen Tipirneni.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 8, 2026Jan 21, 2026$37,500,000fully sold3$12.5MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Caldera Therapeutics's Form D filed Jan 21, 2026.

MD
AR
XS
Xiaodi Su
Director
PT
Praveen Tipirneni
Chief Executive Officer and director

Sources

  1. SECCaldera Therapeutics, Inc. filing history